The discoveries made by the team showed that ABA, an important hormone in many life processes of plants and fruits, is also synthesized in mammals where it regulates basic aspects of metabolic processes that, when malfunctioning, cause disease outbreaks. In particular, the focus of the research was to weigh the implications of ABA in glucose and lipid metabolism.
Experiments in vitro and in vivo demonstrated the capacity of ABA to control blood glucose through a mechanism of action which is not based on increasing insulin secretion but promotes a better muscle uptake of sugar in an insulin-independent manner. Read full publication
The range of ABA doses able to guarantee these results is protected by a patent granted in Europe (EP3169320B1) and in the U.S.A. (US 11,032,021) of which Nutravis is the owner.